The impact of vaccines on the epidemic depends on public trust • Minister Edelstein told Israel Today: "There is no reason to fear - the many information efforts will convince the public"
Prime Minister Benjamin Netanyahu and Health Minister Yuli Edelstein visited the Maccabi HMO vaccination complex at Heichal Shlomo in Tel Aviv yesterday.
"The ability of the health funds in the country to carry out the task shows us that we will probably be able to advance the vaccination to the Israeli population in the best way, in my opinion the best in the world," said the Prime Minister.
Photo: GPO
Netanyahu added: "We are beginning the end of the epidemic. Until then, I want to keep the rules. Israel can get out of this in the best possible way. I ask for your cooperation. On this day, what I can say is that we are on the way to advancing vaccinations."
It is estimated that the operation will be brought forward to next week.
Health Minister Yuli Edelstein said: "It is possible that next week we will start vaccinating medical staffs."
"The stages of preparation are already very practical. There are a lot of 'Pike News', so I can say unequivocally - there is no shortage of medical equipment."
The main challenge facing the funds is the rate of arrival of the vaccinators and the response of the public, because once the vaccines leave the main refrigerators of Teva-Sla, they can be used within five days.
The vaccines themselves are packaged in quantities of about a thousand, so the funds will have to vaccinate in key points that a large number of people will reach. In light of this, and in light of the survey data published yesterday in Israel Today which shows low public response to vaccination, Health Minister A: The vaccine has passed all approvals and is safe.
There is no reason to worry.
I and many others are vaccinated to set a personal example, and I am sure that in the great information efforts, the vast majority of the public will be convinced and go vaccinated. "
AMN:" Limited impact "
The intelligence department report stated that the average daily number of infected last week is 1,700 the volume of paste is very high. "Along with the approval of the emergency, given the weekend vaccine origin of Pfizer, and the beginning of the distribution in Israel and around the world, remember that vaccines are not expected to substantially affect the course of the epidemic in Israel until the end of the current winter."
progress Institute for biological
Meanwhile, The second phase of the Israeli corona vaccine trial developed at the Biological Institute will begin next Sunday, December 20. About a thousand experimenters will participate, half of whom will receive the vaccine dose and half of whom will receive a placebo dose. Towards the beginning of Phase II of the trial at Assuta Ashdod Public Hospital, Dr. Erez Barenbaum, the hospital's director general, clarifies that experimenters will not be denied the opportunity to be vaccinated with Pfizer's vaccine. Part of a groundbreaking, blue-and-white process.
The trial process will not harm any patient's opportunity and ability to receive Pfizer's vaccine. "
Meanwhile, cyber attacks continue: The shipping and logistics company Orian has confirmed to the stock exchange that it is one of 40 shipping and import companies to Israel that were hit by an unprecedented cyber attack last weekend. It is suspected that the attackers managed to break into the servers of dozens of companies and penetrate the supply chain, and is not yet known what information was stolen. experts estimate that the group stands behind the attack Iranian Pay2Key attack in November, dozens of Israeli companies.
contributed to this report Yinon Ben-Shoshan